Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Best Pract Res Clin Haematol. 2008 Mar;21(1):67–77. doi: 10.1016/j.beha.2007.11.005

Figure 1.

Figure 1

Non-relapse mortality (NRM) and relapse (REL) in patients conditioned with standard (conventional intensity) or with reduced intensity conditioning (RIC) regimens. Patients either had not received chemotherapy before HCT (Untreated), had been treated but not achieved remissions (treated, non-CR1) or had achieved complete remissions (CR1). Used with permission from R. Martino et al., Blood; 108:836–846, 2006. This research was originally published in Blood. Rodrigo Martino et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogenic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood. 2006;108 (3):836–46. © the American Society of Hematology.